David A. Siegel Frequency Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.35 - $0.72 $3,570 - $7,344	10,200 New	10,200 $3,000
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $25,235 - $49,734	-24,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.7 - $5.72 $125,460 - $422,136	-73,800 Reduced 75.08%	24,500 $52,000
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $415,305 - $596,529	-83,900 Reduced 46.05%	98,300 $504,000
Q3 2021 Nov 15, 2021	BUY	$6.96 - $9.25 $125,976 - $167,425	18,100 Added 11.03%	182,200 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$8.05 - $11.61 $1.32 Million - $1.91 Million	164,100 New	164,100 $1.63 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.